Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

The Lung Immune Prognostic Index (LIPI) is associated with immune checkpoint inhibitors (ICI) outcomes across different solid tumors, particularly in non-small cell lung cancer. Data regarding the prognostic and/or predictive role of LIPI in metastatic renal cell carcinoma (mRCC) are still scarce. The aim of this study was to evaluate whether LIPI could be predictive of survival in mRCC patients.

Source: European Journal of Cancer - April 8, 2024 Category: Cancer & Oncology Authors: Luci ́a Carril-Ajuria, Pernelle Lavaud, Cecile Dalban, Sylvie Negrier, Gwénaëlle Gravis, Robert J. Motzer, Christine Chevreau, Nizar M. Tannir, Stéphane Oudard, David F. McDermott, Brigitte Laguerre, Hans J. Hammers, Philippe Barthelemy, Elizabeth R. Tags: Original Research Source Type: research